Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis.
Current pharmaceutical design（2016）
摘要
Natalizumab normalizes altered melatonin and norepinephrine levels in MS.
更多查看译文
关键词
Catecholamines,natalizumab,melatonin,norepinephrine,oxidative stress,relapsing-remitting multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要